NORTON HOSPITALS INC
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $11.8M
- Transactions
- 1,387
- Companies
- 40
- Average per transaction
- $8,506
Who reported the payments
| Regeneron | $1,817,740 |
| AstraZeneca | $1,796,327 |
| Merck | $1,109,205 |
| E.r. Squibb & Sons, L.L.C. | $999,169 |
| Angiodynamics, Inc. | $755,925 |
| Genentech, Inc. | $655,231 |
| Acerta Pharma LLC | $576,750 |
| Daiichi Sankyo Inc. | $466,319 |
| Janssen Research & Development, LLC | $429,704 |
| Bristol Myers Squibb | $425,163 |
| Pfizer | $364,925 |
| Morphosys AG | $309,726 |
| Takeda Pharmaceuticals U.S.A., Inc. | $281,378 |
| Jazz Pharmaceuticals Inc. | $266,762 |
| Eli Lilly | $259,376 |
| Zimmer Biomet | $236,145 |
| Roche Products Limited | $209,681 |
| Pharmacyclics LLC, An Abbvie Company | $153,525 |
| TG Therapeutics, Inc. | $62,151 |
| Stryker | $61,158 |
| F. Hoffmann-la Roche AG | $56,734 |
| Astrazeneca UK Limited | $56,571 |
| Epizyme, Inc. | $51,442 |
| Shockwave Medical, Inc | $42,621 |
| Abbott | $32,634 |
| Bayer | $29,140 |
| AbbVie | $28,025 |
| Incyte Corporation | $26,398 |
| Novartis | $23,686 |
| Johnson & Johnson | $20,297 |
| Astellas Pharma Global Development | $18,054 |
| ADC Therapeutics America, Inc. | $17,337 |
| Amgen | $14,515 |
| Icotec Medical Inc. | $14,000 |
| Acumed LLC | $13,940 |
| Medtronic | $11,827 |
| Medline Industries LP | $10,000 |
| Mirati Therapeutics, Inc. | $9,220 |
| Med-el Corporation | $9,090 |
| Arjo Inc. | $7,500 |